Skip to main content

7 Result(s)

within Wolfram Jung Remove this filter

and

  1. Article

    Open Access

    Stem cell transplantation for hemoglobinopathy Vila Real

    Justin Hasenkamp, Joachim Riggert, Wolfram Jung, Hristo Boyadzhiev… in Annals of Hematology (2021)

    Download PDF (514 KB) View Article

  2. No Access

    Article

    Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis

    This phase 3 trial compared tandem autologous stem cell transplantation (autoSCT) versus autoSCT followed by reduced-intensity conditioning allogeneic stem cell transplantation (auto/alloSCT) in patients with ...

    Stefan Knop, Monika Engelhardt, Peter Liebisch, Christoph Meisner, Ernst Holler… in Leukemia (2019)

  3. No Access

    Article

    Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced disease

    Salvage chemotherapy induces disease remissions in patients with relapsed or refractory (r/r) T-cell lymphomas, but fails to provide lasting tumor control. We analyzed the outcome after peripheral blood stem a...

    Gerald Wulf, Justin Hasenkamp, Wolfram Jung… in Bone Marrow Transplantation (2019)

  4. No Access

    Article

    Loss of donor chimerism in remission after allogeneic stem cell transplantation of T-prolymphocytic leukemia patients following alemtuzumab induction therapy

    T-cell prolymphocytic leukemia is a rare aggressive malignancy with low susceptibility to conventional chemotherapy. The anti-CD52 antibody alemtuzumab induces remission, which requires consolidation by stem c...

    Christoph Johannes Szuszies, Justin Hasenkamp… in International Journal of Hematology (2014)

  5. No Access

    Article

    Gene-modified spontaneous Epstein-Barr virus-transformed lymphoblastoid cell lines as autologous cancer vaccines: Mutated p21 ras oncogene as a model

    The transfer of genes coding for tumor antigens (Ags) into Ag-presenting cells is a promising strategy to develop cancer vaccines for patients not limited by major histocompatibility complex restriction. To te...

    Boris Kubuschok, Christiane Cochlovius, Wolfram Jung, Rudolf Schmits… in Cancer Gene Therapy (2000)

  6. No Access

    Article

    Initiation of humoral and cellular immune responses in patients with refractory Hodgkin's disease by treatment with an anti-CD16/CD30 bispecific antibody

    Fifteen patients with refractory Hodgkin's disease were treated in a dose-escalation trial with the bispecific monoclonal antibody (bi-mAb) HRS-3/A9, which is directed against the Fcγ receptor III (CD16 antig...

    Christoph Renner, Frank Hartmann, Wolfram Jung… in Cancer Immunology, Immunotherapy (2000)

  7. Article

    Abstract

    Ch. Mache, Ch. Urban, H. Sauer, G. Brandesky, H. Meßner… in Annals of Hematology (1992)

    Download PDF (18571 KB)